Cargando…

Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis

Objective: To assess the effect of prognostic factors and their impact on survival in male and female breast cancer. Methods: Medical records for men and women diagnosed with breast cancer referred to the cancer center for treatment were reviewed. Patients with distant metastatic diseases were exclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Edward, Stitt, Larry, Vujovic, Olga, Joseph, Kurian, Assouline, Avi, Younus, Jawaid, Perera, Francisco, Tai, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652922/
https://www.ncbi.nlm.nih.gov/pubmed/26623210
http://dx.doi.org/10.7759/cureus.355
_version_ 1782401838311538688
author Yu, Edward
Stitt, Larry
Vujovic, Olga
Joseph, Kurian
Assouline, Avi
Younus, Jawaid
Perera, Francisco
Tai, Patricia
author_facet Yu, Edward
Stitt, Larry
Vujovic, Olga
Joseph, Kurian
Assouline, Avi
Younus, Jawaid
Perera, Francisco
Tai, Patricia
author_sort Yu, Edward
collection PubMed
description Objective: To assess the effect of prognostic factors and their impact on survival in male and female breast cancer. Methods: Medical records for men and women diagnosed with breast cancer referred to the cancer center for treatment were reviewed. Patients with distant metastatic diseases were excluded. Data on prognostic factors including age, nodal status, resection margin, use of hormonal therapy, chemotherapy with and without hormone and radiation therapy (RT), survival, and recurrence were analyzed. Survival estimates were obtained using Kaplan-Meier methodology. The Cox regression interaction was used to compare male and female differences in prognostic factors. Male breast cancer (MBC) and female breast cancer (FBC) were matched according to propensity scores and survival compared using Cox regression. Results: From 1963-2006, there were 75 MBC and 1,313 FBC totaling 1,388 breast cancers. The median age of the cohort was 53 (range: 23-90) years. Median follow-up was 90 (range: 0.4-339) months. Prognostic factors of patients were balanced among the groups after adjusting for propensity scores. A Cox model adjusting for propensity scores showed that overall survival (OS) (HR= 2.52 (1.65, 3.86), P<0.001) and distant disease recurrence-free survival (DDRFS) (HR= 2.39 (0.75, 3.04), P=0.003) were significantly different for MBC and FBC. Analyses that stratified by propensity score quintiles had similar findings: OS HR=2.41 (1.67, 3.47), P<0.001); DDRFS HR=2.89 (1.81, 4.60), P<0.001). When MBC and FBC were matched (1:3) by propensity scores, differences between MBC and FBC were again observed in OS (HR=1.94, 95%CI:1.18-3.19, P=0.009) and DDRFS (HR=2.79, 95%CI:1.36-5.75, P=0.005) with MBC at a higher risk of death and  disease recurrence compared to FBC . Conclusion: This large series showed that MBC and FBC survivals are not similar, with MBC having a worse outcome. The finding of this study needs confirmation from a complete prospective database.
format Online
Article
Text
id pubmed-4652922
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-46529222015-11-30 Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis Yu, Edward Stitt, Larry Vujovic, Olga Joseph, Kurian Assouline, Avi Younus, Jawaid Perera, Francisco Tai, Patricia Cureus Radiation Oncology Objective: To assess the effect of prognostic factors and their impact on survival in male and female breast cancer. Methods: Medical records for men and women diagnosed with breast cancer referred to the cancer center for treatment were reviewed. Patients with distant metastatic diseases were excluded. Data on prognostic factors including age, nodal status, resection margin, use of hormonal therapy, chemotherapy with and without hormone and radiation therapy (RT), survival, and recurrence were analyzed. Survival estimates were obtained using Kaplan-Meier methodology. The Cox regression interaction was used to compare male and female differences in prognostic factors. Male breast cancer (MBC) and female breast cancer (FBC) were matched according to propensity scores and survival compared using Cox regression. Results: From 1963-2006, there were 75 MBC and 1,313 FBC totaling 1,388 breast cancers. The median age of the cohort was 53 (range: 23-90) years. Median follow-up was 90 (range: 0.4-339) months. Prognostic factors of patients were balanced among the groups after adjusting for propensity scores. A Cox model adjusting for propensity scores showed that overall survival (OS) (HR= 2.52 (1.65, 3.86), P<0.001) and distant disease recurrence-free survival (DDRFS) (HR= 2.39 (0.75, 3.04), P=0.003) were significantly different for MBC and FBC. Analyses that stratified by propensity score quintiles had similar findings: OS HR=2.41 (1.67, 3.47), P<0.001); DDRFS HR=2.89 (1.81, 4.60), P<0.001). When MBC and FBC were matched (1:3) by propensity scores, differences between MBC and FBC were again observed in OS (HR=1.94, 95%CI:1.18-3.19, P=0.009) and DDRFS (HR=2.79, 95%CI:1.36-5.75, P=0.005) with MBC at a higher risk of death and  disease recurrence compared to FBC . Conclusion: This large series showed that MBC and FBC survivals are not similar, with MBC having a worse outcome. The finding of this study needs confirmation from a complete prospective database. Cureus 2015-10-16 /pmc/articles/PMC4652922/ /pubmed/26623210 http://dx.doi.org/10.7759/cureus.355 Text en Copyright © 2015, Yu et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Radiation Oncology
Yu, Edward
Stitt, Larry
Vujovic, Olga
Joseph, Kurian
Assouline, Avi
Younus, Jawaid
Perera, Francisco
Tai, Patricia
Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis
title Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis
title_full Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis
title_fullStr Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis
title_full_unstemmed Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis
title_short Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis
title_sort male breast cancer prognostic factors versus female counterparts with propensity scores and matched-pair analysis
topic Radiation Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652922/
https://www.ncbi.nlm.nih.gov/pubmed/26623210
http://dx.doi.org/10.7759/cureus.355
work_keys_str_mv AT yuedward malebreastcancerprognosticfactorsversusfemalecounterpartswithpropensityscoresandmatchedpairanalysis
AT stittlarry malebreastcancerprognosticfactorsversusfemalecounterpartswithpropensityscoresandmatchedpairanalysis
AT vujovicolga malebreastcancerprognosticfactorsversusfemalecounterpartswithpropensityscoresandmatchedpairanalysis
AT josephkurian malebreastcancerprognosticfactorsversusfemalecounterpartswithpropensityscoresandmatchedpairanalysis
AT assoulineavi malebreastcancerprognosticfactorsversusfemalecounterpartswithpropensityscoresandmatchedpairanalysis
AT younusjawaid malebreastcancerprognosticfactorsversusfemalecounterpartswithpropensityscoresandmatchedpairanalysis
AT pererafrancisco malebreastcancerprognosticfactorsversusfemalecounterpartswithpropensityscoresandmatchedpairanalysis
AT taipatricia malebreastcancerprognosticfactorsversusfemalecounterpartswithpropensityscoresandmatchedpairanalysis